摘要
目的:探讨醒脑静注射液对中重度颅脑损伤患者氧化应的影响。方法:将2013年11月-2016年1月在我院接受治疗的60例中重度颅脑损伤患者作为研究对象,并随机分为两组:对照组30例,给予常规治疗;试验组30例,在常规治疗基础上给予醒脑静注射液治疗。对两组患者治疗前后的昏迷评分(GCS评分)、静脉血丙二醛(MDA)、超氧化物歧化酶(SOD)以及肿瘤坏死因子(TNF-α)等指标进行检测并对其临床治疗效果进行综合评价。结果:试验组患者治疗后的GCS评分得到明显改善,显著优于对照组(P<0.05),差异有统计学意义;试验组患者治疗后的MDA、SOD、TNF-α等相关指标与对照组存在明显差异(P<0.05),差异有显著的统计学意义;试验组治疗后有28例患者有效,总有效率为93.3%,显著高于对照组的70.0%(P<0.05)。结论:在常规治疗基础上对中重度颅脑损伤患者给予醒脑静注射液治疗,不仅能显著提高临床疗效,而且对患者的氧化应激状态具有显著的抑制作用。
Objective: To investigate efficacy of the Xingnaojing injection( 醒脑静注射液) on oxidative stress in patients with moderately severe craniocerebral injury. Methods: 60 patients were divided into two groups, 30 cases in each group. The control group was given conventional treatment; the treatment group took the Xingnaojing injection more. Results: GCS score in the treatment group was obviously improved and significantly better than the control group(P〈0.05). MDA, SOD, TNF-α exists significant difference between two groups(P〈0.05). The total efficiency in the treatment group was 93.3% and significantly higher than 70.0% in the control group(P〈0.05). Conclusion: The Xingnaojing injection plus conventional treatment was effective, and has significant inhibitory effects on the oxidative stress status.
出处
《中医临床研究》
2018年第11期61-63,共3页
Clinical Journal Of Chinese Medicine
关键词
醒脑静注射液
中重度颅脑损伤
氧化应激
临床疗效
The Xingnaojing injection
Moderately severe craniocerebral injury
Oxidative stress
Clinical curative efects